Back to Trades
Honczarenko Marek
EVPChief Scientific OfficerCIK 0002089105
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 2 filings between 2025–2026, Honczarenko Marek, EVP, Chief Scientific Officer, has disclosed $0 in transactions — all concentrated in Keenova Therapeutics plc (NONE). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Feb 26 | NONE Keenova Therapeutics plc | Honczarenko Marek | EVP, Chief Scientific Officer | Award | $0 |
| Oct 1 | NONE Mallinckrodt plc | Honczarenko Marek | EVP & Chief Scientific Officer | Other | $0 |
2 filings